Related Experiment Video
Updated: Sep 6, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Anticoagulation for left ventricular thrombi secondary to COVID-Is 3 months too long?
Rimmy Garg1,2, Amitoj Sachdeva1, Juan Del Cid Fratti1,2
1University of Illinois College of Medicine Peoria Peoria Illinois USA.
Insights
The optimal duration of anticoagulation for COVID-19-related blood clots is unclear. This case study suggests 8 weeks may be sufficient for left ventricular thrombi following a heart attack.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- Thrombotic events are a known complication of COVID-19.
- The optimal anticoagulation strategy for COVID-19-associated thrombosis, particularly left ventricular thrombus, remains undefined.
- Left ventricular thrombus formation can lead to embolic complications.
Abstract:
The length of anticoagulation for thrombotic events related to COVID-19 is unknown. We present a patient with COVID-19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoagulation with COVID-19-related LV thrombus.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Myocarditis III: Medical Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endocarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

